Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Tag: Pharmaceutical Deal
Rentschler Biopharma buys US manufacturing facility from Shire
Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.
Trimb Healthcare acquires BioClin BV
Trimb Healthcare (Sweden) has completed the acquisition of BioClin BV, a leading intimate healthcare company based in Delft (Netherlands).
Biotage acquires new technology platform suited for biopharma industry
Biotage AB, a global life science company, has entered into an agreement to acquire the privately held company PhyNexus (California, USA) for a total purchase price of $21.5 million.
AGC buys API manufacturer from Boehringer Ingelheim
AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals.
Janssen signs collaboration and license agreement with Dutch biotech
argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies announced an exclusive agreement with Janssen.
GSK acquires promising biopharma company Tesaro
GlaxoSmithKline announced that it will acquire TESARO, an oncology-focused company for an aggregate cash consideration of approximately $5.1 billion.
Genentech obtains rights to preclinical portfolio of Jecure Therapeutics
Jecure Therapeutics, a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced it will be acquired by Genentech, a member of the Roche Group.
Telix Pharmaceuticals buys Advanced Nuclear Medicine Ingredients
Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company, has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI).
Sun Pharma to acquire Japanese drug manufacturer
Sun Pharma announced it has entered into a agreement to acquire Pola Pharma, a company engaged in research and development, manufacture, sale and distribution of branded and generic products.
MorphoSys signed agreement with I-Mab for a novel immuno-oncology agent
MorphoSys and I-Mab Biopharma, a biotech company focused on onimmuno-oncology and autoimmune diseases, jointly announced that they have entered into an exclusive strategic collaboration
Grünenthal buys US pharma company Averitas Pharma
Grünenthal, a German research-based pharmaceutical company focused on pain treatment products, announced that it has acquired the US-based pharmaceutical company Averitas Pharma.
Hikma Pharmaceuticals acquires Medlac Pharma Italy
Hikma Pharmaceuticals entered into an agreement to acquire 100 per cent of the share capital of Medlac Pharma Italy, an injectable manufacturing company in Vietnam.
RCIF and AFK Sistema invest 19 billion rubles in ‘Obolenskoye’ pharma holding
The Russia-China Investment Fund (RCIF) and AFK Sistema have agreed to establish a leading pharmaceutical company in Russia with a total investment of over 19 billion rubles.
BioTime aimed to become a premier cellular therapy company
BioTime and Asterias Biotherapeutics announced that they have entered into a definitive merger agreement whereby BioTime will acquire all of the remaining outstanding common stock of Asterias.
Sygnature Discovery signs drug discovery deal with Sitryx Therapeutics
Sygnature Discovery announced a multi-target, integrated drug discovery collaboration with Sitryx Therapeutics to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.
AstraZeneca sells its rights for three corticosteroid drugs to Covis Pharma
AstraZeneca has entered into an agreement with Covis Pharma B.V. (Switzerland) to sell its rights to the medicines Alvesco (ciclesonide), and Omnaris and Zetonna (ciclesonide).
Page 1 of 9
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs
Active pharmaceutical substance for preparation of sterile and non-sterile drug products
Suitable for pharmaceutical oral & infusion formulations
Made in Germany
TOP 30 Pharmaceutical Contract Manufacturing Organisations
EAEU May Allow to Register Empty Primary Packages as Medical...
GMP Inspection Practice: a Case for Global Benchmarking, Con...
Regulation of Autogenous Vaccines
Inspection of Foreign Manufacturers of Veterinary Products
FDA Approved XCOPRI to Treat Partial-Onset Seizures
Subscribe to Newsletter!
© GMP news